Craneware plc Earnings Recaps
Q4 2026
Sep 24, 2026
Craneware shares rose 5.6% after earnings. The company acknowledged a disappointing FY26 slowdown in 340B transactional revenue, but highlighted recurring revenue of $185 million and said it is resetting FY27 expectations to its ARR base while it assesses uncertainty from 340B and a cybersecurity incident.
Key takeaways
- Management attributed the late-year 340B slowdown to manufacturers restricting the supply of drugs at 340B pricing.
- Recurring revenue was $185 million; net revenue retention was 100%, and customer retention was greater than 90%.
- The company reported strong EBITDA performance and cash generation, but did not provide figures in the excerpt.
- Craneware is rebasing FY27 numbers to its ARR level and undertaking a comprehensive cost-base review.
- Following a July cyber incident, the company said threat actors were removed within 24 hours and operations continued. Some staff, customer, and patient details were among the files taken; the full financial impact remains under assessment.